WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited

Area of Science:

• Oncology
• Cancer Biology
• Molecular Signaling

Background:

• Cholangiocarcinoma (CC) is a challenging cancer often diagnosed at advanced stages.
• Current treatments for CC have limited efficacy, and incidence is increasing globally.
• The underlying mechanisms driving CC progression remain incompletely understood.

Purpose of the Study:

• To investigate the role of the WNT pathway in cholangiocarcinoma.
• To explore the potential of targeting WNT signaling as a therapeutic strategy for CC.

Main Methods:

• Utilized multiple models including human tissues, CC cell xenografts, a p53-deficient transgenic mouse model, and a chemically induced rat model.
• Assessed WNT pathway activation and the role of inflammatory macrophages in CC.
• Tested the efficacy of WNT signaling inhibitors in preclinical CC models.

Main Results:

• The WNT pathway was found to be highly activated in cholangiocarcinoma.
• Inflammatory macrophages were identified as crucial for establishing the WNT-high state in vivo.
• Inhibition of WNT signaling significantly reduced CC proliferation and induced apoptosis, leading to tumor regression in preclinical models.

Conclusions:

• Enhanced WNT signaling is a key characteristic of cholangiocarcinoma.
• Targeting WNT signaling pathways represents a promising therapeutic approach for cholangiocarcinoma.
• The interplay between inflammatory macrophages and WNT signaling is critical in CC progression.